On April 6, 2018, Vanderbilt University and Deerfield Management announced the launch of Ancora Innovation, a collaboration focused on the union of Vanderbilt’s innovative life science discovery efforts and Deerfield’s commitment to accelerating state-of-the-art drug development. Deerfield will fund Ancora Innovation with up to $65 million to pursue novel therapeutics and will provide additional capital to fund successful start-up companies that spin out of Ancora.
Deerfield is a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com.
Vanderbilt University is a recognized center for chemical biology and therapeutic discovery, with multiple commercial partnerships to advance novel agents. University and Medical Center researchers are at the forefront of translational science and medicine.